Selectis Health ( (GBCS) ) has released a notification of late filing.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Selectis Health, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The primary reason for the delay is the company’s inability to complete the preparation of its unaudited financial statements for the quarter. Selectis Health has assured stakeholders that the report will be filed within five calendar days following the prescribed due date. The company does not anticipate any significant changes in its financial results compared to the corresponding period of the previous fiscal year. This notification was signed by Adam Desmond, CEO, reflecting the company’s commitment to ongoing compliance and transparency.
Spark’s Take on GBCS Stock
According to Spark, TipRanks’ AI Analyst, GBCS is a Underperform.
Selectis Health is facing significant financial difficulties, highlighted by consistent net losses, high leverage, and negative equity, which severely impact its financial stability. The bearish technical indicators and negative valuation metrics further underscore the challenges facing the company. The lack of earnings call data or corporate events means these factors are not mitigating the overall negative outlook.
To see Spark’s full report on GBCS stock, click here.
More about Selectis Health
Average Trading Volume: 3,175
Technical Sentiment Signal: Sell
Current Market Cap: $6.13M
For an in-depth examination of GBCS stock, go to TipRanks’ Stock Analysis page.